These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 15573925)

  • 1. Knowledge, quality of life, and use of complementary and alternative medicine and therapies in inflammatory bowel disease: a comparison of Chinese and Caucasian patients.
    Leong RW; Lawrance IC; Ching JY; Cheung CM; Fung SS; Ho JN; Philpott J; Wallace AR; Sung JJ
    Dig Dis Sci; 2004 Oct; 49(10):1672-6. PubMed ID: 15573925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive factors of complementary and alternative medicine use for patients with inflammatory bowel disease in Korea.
    Park DI; Cha JM; Kim HS; Park HJ; Shin JE; Hong SN; Hong SS; Kim WJ
    Complement Ther Med; 2014 Feb; 22(1):87-93. PubMed ID: 24559822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of complementary and alternative medicine on the quality of life in inflammatory bowel disease: results from a French national survey.
    Abitbol V; Lahmek P; Buisson A; Olympie A; Poupardin C; Chaussade S; Lesgourgues B; Nahon S
    Eur J Gastroenterol Hepatol; 2014 Mar; 26(3):288-94. PubMed ID: 24407360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of complementary and alternative medicine use and its impact on medication adherence in inflammatory bowel disease.
    Weizman AV; Ahn E; Thanabalan R; Leung W; Croitoru K; Silverberg MS; Steinhart AH; Nguyen GC
    Aliment Pharmacol Ther; 2012 Feb; 35(3):342-9. PubMed ID: 22176478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development, validation, and application of a novel tool to measure disease-related knowledge in patients with inflammatory bowel disease.
    Yoon H; Yang SK; So H; Lee KE; Park SH; Jung SA; Choh JH; Shin CM; Park YS; Kim N; Lee DH
    Korean J Intern Med; 2019 Jan; 34(1):81-89. PubMed ID: 29172400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and indicators of use of complementary and alternative medicine in Austrian patients with inflammatory bowel disease.
    Gröchenig HP; Waldhör T; Haas T; Wenzl H; Steiner P; Koch R; Feichtenschlager T; Eckhardt G; Mayer A; Kirchgatterer A; Ludwiczek O; Platzer R; Papay P; Gartner J; Fuchssteiner H; Miehsler W; Peters PG; Reicht G; Kutschera M; Dejaco C; Vogelsang H; Novacek G;
    Eur J Gastroenterol Hepatol; 2019 Oct; 31(10):1211-1219. PubMed ID: 31498280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complementary alternative medicine in patients with inflammatory bowel disease: use and attitudes.
    Quattropani C; Ausfeld B; Straumann A; Heer P; Seibold F
    Scand J Gastroenterol; 2003 Mar; 38(3):277-82. PubMed ID: 12737442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of complementary therapies by patients with IBD may indicate psychosocial distress.
    Langmead L; Chitnis M; Rampton DS
    Inflamm Bowel Dis; 2002 May; 8(3):174-9. PubMed ID: 11979137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementary and alternative medicine in patients with inflammatory bowel disease: A survey performed in a tertiary center in Chile.
    Fernández A; Simian D; Quera R; Flores L; Ibáñez P; Lubascher J; Figueroa C; Kronberg U; Pizarro G; Fluxá D
    Complement Ther Med; 2018 Oct; 40():77-82. PubMed ID: 30219473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of complementary and alternative medicine and low quality of life associate with the need for psychological and psychotherapeutic interventions in inflammatory bowel disease.
    Kutschera M; Waldhör T; Gröchenig HP; Haas T; Wenzl H; Steiner P; Koch R; Feichtenschlager T; Eckhardt G; Mayer A; Kirchgatterer A; Ludwiczek O; Platzer R; Papay P; Gartner J; Fuchssteiner H; Peters PG; Reicht G; Moser G; Dejaco C; Vogelsang H; Primas C; Novacek G; Miehsler W;
    United European Gastroenterol J; 2021 Feb; 9(1):72-81. PubMed ID: 32723070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IBD-INFO Questionnaire: A Multicenter French Up-to-Date Survey of Patient Knowledge in Inflammatory Bowel Disease.
    Danion P; Buisson A; Roblin X; Mathieu N; Charlois AL; Borgerding JN; Williet N; Del Tedesco E; Flourié B; Nancey S; Boschetti G
    Inflamm Bowel Dis; 2018 Apr; 24(5):943-952. PubMed ID: 29506217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sources of information and factual knowledge in Europeans with inflammatory bowel diseases: a cross-cultural comparison between German and Irish patients.
    Blumenstein I; McDermott E; Keegan D; Byrne K; Ellison M; Doherty G; Schröder O; Mulcahy H
    J Crohns Colitis; 2013 Oct; 7(9):e331-6. PubMed ID: 23453429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Better disease specific patient knowledge is associated with greater anxiety in inflammatory bowel disease.
    Selinger CP; Lal S; Eaden J; Jones DB; Katelaris P; Chapman G; McDonald C; Leong RW; McLaughlin J
    J Crohns Colitis; 2013 Jul; 7(6):e214-8. PubMed ID: 23062330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Randomized Controlled Trial of TELEmedicine for Patients with Inflammatory Bowel Disease (TELE-IBD).
    Cross RK; Langenberg P; Regueiro M; Schwartz DA; Tracy JK; Collins JF; Katz J; Ghazi L; Patil SA; Quezada SM; Beaulieu D; Horst SN; Russman K; Riaz M; Jambaulikar G; Sivasailam B; Quinn CC
    Am J Gastroenterol; 2019 Mar; 114(3):472-482. PubMed ID: 30410041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doctor communication quality and Friends' attitudes influence complementary medicine use in inflammatory bowel disease.
    Mountifield R; Andrews JM; Mikocka-Walus A; Bampton P
    World J Gastroenterol; 2015 Mar; 21(12):3663-70. PubMed ID: 25834335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementary and alternative medicine use by patients with inflammatory bowel disease: results from a postal survey.
    Bensoussan M; Jovenin N; Garcia B; Vandromme L; Jolly D; Bouché O; Thiéfin G; Cadiot G
    Gastroenterol Clin Biol; 2006 Jan; 30(1):14-23. PubMed ID: 16514377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced Unplanned Care and Disease Activity and Increased Quality of Life After Patient Enrollment in an Inflammatory Bowel Disease Medical Home.
    Regueiro M; Click B; Anderson A; Shrank W; Kogan J; McAnallen S; Szigethy E
    Clin Gastroenterol Hepatol; 2018 Nov; 16(11):1777-1785. PubMed ID: 29654918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of inflammatory bowel disease on Japanese patients' quality of life: results of a patient questionnaire survey.
    Ueno F; Nakayama Y; Hagiwara E; Kurimoto S; Hibi T
    J Gastroenterol; 2017 May; 52(5):555-567. PubMed ID: 27470433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of complementary medicine in European and Asian patients with inflammatory bowel disease.
    Moody GA; Eaden JA; Bhakta P; Sher K; Mayberry JF
    Public Health; 1998 Jul; 112(4):269-71. PubMed ID: 9724953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of complementary and alternative medicine in Germany - a survey of patients with inflammatory bowel disease.
    Joos S; Rosemann T; Szecsenyi J; Hahn EG; Willich SN; Brinkhaus B
    BMC Complement Altern Med; 2006 May; 6():19. PubMed ID: 16716218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.